The decision comes after the health system put the requirement in place Oct. 24.
In its statement, Berkshire points to recent data showing the bivalent booster to be as much as 70 percent to 80 percent effective at reducing the severity of COVID illness, but that it may be less effective at preventing virus transmission.
“This expected change in efficacy in preventing transmission requires that we renew our focus on masking and other similar protocols as the primary measures to protect patients and co-workers from transmission,” the statement read. “Additionally, because BHS maintains safe care environments and adapts as necessary to evolving data, emerging variants of the virus, novel treatments and prevention strategies, and shifting laws, regulations and guidance from public health agencies, we are withdrawing the bivalent booster requirement.”
Berkshire said it still strongly recommends all employees and patients be vaccinated with the bivalent booster dose.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
